| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 西安康拓医疗技术股份有限公司（下称“西安康拓”）成立于2005年，专注于神经外科、心血管外科、颅颌面外科、口腔科等专业领域，是一家集三类植入医疗器械的研发、生产和销售服务为一体的高新技术企业。 西安康拓自成立以来，植根于医用钛金属和高分子材料的研发、加工和生产，目前取得植入类医疗器械专利十余项和产品注册证多项；西安康拓在自主研发生产的同时放眼国际，在全球范围内寻求新技术、新产品，力求为中国的医生与患者提供更好的产品及服务。 西安康拓研发生产基地位于西安市，拥有设备：TORNOS高精度数控机床、沙迪克线切割放电加工机、多轴联动立式加工中心，万级洁净车间。 西安康拓视产品质量和服务品质为企业的生命线，本着“专业品质，精益求精”的工作态度，以“服务中国医疗，振兴民族品牌”为宏愿，积极投身于祖国的医疗健康事业！ 公司作为专注于三类植入医疗器械产品研发、生产与销售的高新技术企业，其核心产品聚焦于神经外科颅骨修补固定领域，并延伸至心胸外科胸骨固定、口腔科、颌面修复及皮肤填充等多个细分领域，其中PEEK材料颅骨修补和固定产品在国内市场占据领先地位，彰显了公司技术实力与市场竞争力。近年来，随着全球及中国人口老龄化的加速推进，对高质量医疗服务的需求日益增长，加之民众健康意识的普遍提升、医疗改革的持续深化以及全国及区域性集中采购政策的实施，特别是“一带一路”开放战略的推动，为公司等高值耗材生产企业带来了前所未有的发展机遇，促进了高值医疗耗材在临床应用的快速放量，同时激发了国产医疗器械在海外市场的持续增长潜力。 | ||||||||||||||||||||||||
| Main Business | 三类植入医疗器械产品研发、生产、销售 | ||||||||||||||||||||||||
| Legal Representative | 胡立人 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 周欢 | ||||||||||||||||||||||||
| Solicitors | 国浩律师（西安）事务所 | ||||||||||||||||||||||||
| Auditors | 中审众环会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 029-68318314 | ||||||||||||||||||||||||
| Fax No | 029-85727403 | ||||||||||||||||||||||||
| Website | www.kontourmedical.com | ||||||||||||||||||||||||
| public@kontmed.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 18/05/2021 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.930 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.320 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 7.228 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 2.453B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |